封面
市場調查報告書
商品編碼
1391913

Esoteric測試市場:依類型、依技術、依服務供應商、依地區

Esoteric Testing Market, By Type, By Technology, By Service Provider, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

Esoteric 測試市場規模預計將從 2023 年的 259 億美元增至 2030 年的 549 億美元,預測期內複合年成長率為 11.3%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 259億美元
實績資料 2018-2021 預測期 2023-2030
預測期複合年成長率 11.30% 2030年市場規模預測 549億美元
圖 1. 2023 年全球市場佔有率(%)(依地區)
Esoteric測試市場-IMG1

近年來,隨著技術和醫學研究的進步促使高度專業化的診斷測試的發展,Esoteric測試領域受到了極大的關注。Esoteric測試是不常見的實驗室測試,需要專門的設備、專業知識和解釋。這些檢查通常用於診斷罕見疾病、監測治療效果並提供個人化醫療解決方案。

由於慢性病盛行率的增加、基因檢測的進步以及個人化醫療需求的不斷成長等因素,全球Esoteric測試市場正在顯著成長。Esoteric測試在識別基因突變、生物標記和其他分子異常方面發揮重要作用,有助於早期疾病檢測和治療。

市場動態:

全球Esoteric測試市場主要是由癌症、心血管疾病和自體免疫疾病等慢性疾病盛行率上升所推動的。Esoteric測試使醫療專業人員能夠識別與這些疾病相關的特定基因突變和生物標記物,從而促進早期診斷和個體化治療計劃。此外,精準醫學和標靶治療的日益普及也進一步推動了對Esoteric測試的需求。

然而,Esoteric測試面臨成本高、報銷政策不充分等挑戰。由於執行這些測試需要專門的設備和專業知識,困難的測試通常價格昂貴。此外,保險公司承保範圍有限也阻礙了這些測試的廣泛普及,特別是在發展中地區。

儘管存在這些挑戰,市場仍存在一些成長機會。對預防性醫療保健的日益關注以及對早期疾病檢測益處的日益認知預計將推動對Esoteric測試的需求。此外,次世代定序和分子診斷等技術進步可能會提高Esoteric測試的準確性和效率,為市場擴張開闢新途徑。

本研究的主要特點

  • 本報告對全球 Esoteric 測試市場進行了詳細分析,包括以 2022 年為基準年的預測期(2023-2030)的市場規模和年複合成長率(CAGR%)。
  • 它還揭示了各個區隔市場的潛在商機,並為該市場說明了一系列有吸引力的投資提案。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 該報告的見解將使公司行銷人員和負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出資訊的決策。
  • 本研究報告針對該產業的各個相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 透過用於分析全球持續測試市場的各種策略矩陣,將有助於相關人員做出決策。

目錄

第1章 研究目的與假設

  • 研究目標
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規及趨勢分析

  • 市場動態
    • 促進因素
  • 慢性病及感染疾病率增加
    • 抑制因素
  • 費用高且報銷不足
    • 機會
  • 照護端Esoteric測試
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 併購場景

第 4 章 Esoteric測試市場 –冠狀病毒(COVID-19) 大流行的影響

  • 新型冠狀病毒感染疾病(COVID-19)的流行病學
  • 供需面分析
  • 經濟影響

第 5 章 Esoteric測試市場,依類型,2018-2030

  • 介紹
  • 內分泌學
  • 腫瘤學
  • 分子診斷
  • 神經病學
  • 免疫學
  • 基因檢測
  • 其他

第 6 章 Esoteric測試市場(依技術),2018-2030

  • 介紹
  • 質譜
  • 即時螢光定量PCR
  • 流式細胞儀
  • 化學冷光
  • 酵素連結免疫吸附試驗
  • 免疫測量
  • 其他

第 7 章 Esoteric測試市場,依服務供應商分類,2018-2030

  • 介紹
  • 獨立實驗室和參考實驗室
  • 醫院實驗室
  • 專科診所
  • 其他

第 8 章 2018-2030 年Esoteric測試市場(依地區)

  • 介紹
  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 歐洲其他地區
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 東南亞國協
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章競爭形勢

  • LabCorp
  • Quest Diagnostics
  • OPKO Health
  • Miraca Holdings
  • Myriad Genetics
  • Sonic Healthcare
  • Cardio Diagnostics Holdings, Inc
  • Veravas
  • BPGbio, Inc.
  • Fulgent Genetics
  • Alveo Technologies, Inc.
  • RL Diagnostics

第10章

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6261

The esoteric testing market size is expected to reach US$ 54.9 billion by 2030, from US$ 25.9 million in 2023, at a CAGR of 11.3% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 25.9 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 11.30% 2030 Value Projection: US$ 54.9 Bn
Figure 1. Global Esoteric Testing Market Share (%), by Region, 2023
Esoteric Testing Market - IMG1

The field of esoteric testing has gained significant attention in recent years, as advancements in technology and medical research have allowed for the development of highly specialized diagnostic tests. Esoteric testing refers to laboratory tests that are not commonly performed and require specialized equipment, expertise, and interpretation. These tests are often used to diagnose rare diseases, monitor treatment effectiveness, and provide personalized healthcare solutions.

The global esoteric testing market is witnessing substantial growth, driven by factors such as the increasing prevalence of chronic diseases, advancements in genetic testing, and the growing demand for personalized medicine. Esoteric testing plays a crucial role in identifying genetic mutations, biomarkers, and other molecular abnormalities that can help in the early detection and treatment of diseases.

Market Dynamics:

The global esoteric testing market is primarily driven by the rising incidence of chronic diseases, such as cancer, cardiovascular diseases, and autoimmune disorders. Esoteric tests enable healthcare professionals to identify specific genetic mutations and biomarkers associated with these diseases, facilitating early diagnosis and personalized treatment plans. Moreover, the growing adoption of precision medicine and targeted therapies further fuels the demand for esoteric testing.

However, the market faces certain challenges, including the high cost of esoteric tests and the lack of reimbursement policies. Esoteric tests are often expensive due to the specialized equipment and expertise required for their execution. Additionally, the limited coverage by insurance providers hinders the widespread adoption of these tests, particularly in developing regions.

Despite these challenges, the market presents several opportunities for growth. The increasing focus on preventive healthcare and the rising awareness about the benefits of early disease detection are expected to drive the demand for esoteric testing. Furthermore, advancements in technology, such as next-generation sequencing and molecular diagnostics, are likely to enhance the accuracy and efficiency of esoteric tests, opening new avenues for market expansion.

Key Features of the Study:

  • This report provides an in-depth analysis of the global esoteric testing market, including market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), with 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • Key companies covered as a part of this study include LabCorp, Quest Diagnostics, OPKO Health, Miraca Holdings, Myriad Genetics, Sonic Healthcare, Cardio Diagnostics Holdings, Inc, Veravas, BPGbio, Inc., Fulgent Genetics, Alveo Technologies, Inc., and S.R.L. Diagnostics
  • Insights from this report would allow marketers and management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global esoteric testing market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global esoteric testing market

Esoteric Testing Market Segmentation

  • By Type
    • Endocrinology
    • Oncology
    • Molecular Diagnostics
    • Neurology
    • Immunology
    • Genetic Testing
    • Others
  • By Technology
    • Mass Spectrometry
    • Real Time PCR
    • Flow Cytometry
    • Chemiluminescence
    • ELISA
    • Radioimmunoassay
    • Others
  • By Service Provider
    • Independent & Reference Labs
    • Hospital-based Labs
    • Specialty Clinics
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top Companies in Esoteric Testing Market
    • LabCorp
    • Quest Diagnostics
    • OPKO Health
    • Miraca Holdings
    • Myriad Genetics
    • Sonic Healthcare
    • Cardio Diagnostics Holdings, Inc
    • Veravas
    • BPGbio, Inc.
    • Fulgent Genetics
    • Alveo Technologies, Inc.
    • S.R.L. Diagnostics

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Esoteric Testing, By Type
    • Market Esoteric Testing, By Technology
    • Market Esoteric Testing, By Service Provider
    • Market Esoteric Testing, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Rising prevalence of chronic and infectious diseases
    • Restraints
  • High costs and inadequate reimbursements
    • Opportunities
  • Point-of-care esoteric testing
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Esoteric Testing Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Esoteric Testing Market, By Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Endocrinology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Molecular Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Immunology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Genetic Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Esoteric Testing Market, By Technology, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019- 2030
    • Segment Trends
  • Mass Spectrometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Real Time PCR
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Flow Cytometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Chemiluminescence
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • ELISA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Radioimmunoassay
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Esoteric Testing Market, By Service Provider, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019- 2030
    • Segment Trends
  • Independent & Reference Labs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Hospital-based Labs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Esoteric Testing Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2019-2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • LabCorp
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Quest Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • OPKO Health
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Miraca Holdings
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Myriad Genetics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sonic Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Cardio Diagnostics Holdings, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Veravas
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BPGbio, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Fulgent Genetics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Alveo Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • R.L. Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us